CircSMARCA5 can not only screen for liver cancer but also has the ability to distinguish between liver fibrosis and hepatitis, and may be used as a screening indicator for cancer together with alpha-fetoprotein. This evidence concerns the gene AFP and Hepatic fibrosis.